MEKK3-KLF2/4 pathway has already been implicated in CCM lesion formation[90], which is further validated by decreased expression of KLF2/KLF4 with an LPS injection, suggesting the existence of TLR4-MEKK3-KLF2/4 pathway. Here, MAP3K3 is linked to cerebral cavernous malformation.